Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Subscribe
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Alzheimer's Association
Payers
CMS won’t cover lecanemab without more proof of its effectiveness
CMS and the VA are two different agencies facing different challenges, which is one of the rea-sons CMS won’t cover the Alzheimer’s medication lecanemab for now.
Frank Diamond
Mar 14, 2023 5:00pm
CMS wants more data before rethinking Alzheimer's drug coverage
Feb 23, 2023 3:50pm
Industry Voices—An 'Operation Warp Speed' for Alzheimer's
Jan 8, 2021 12:34pm
50% of PCPs aren't ready for increase in Alzheimer's patients
Mar 11, 2020 3:10pm
Doctor denies allegations he ordered fatal pain drugs—Roundup
Mar 7, 2019 2:11pm
Doctors give patients 11 seconds before interrupting—roundup
Jul 24, 2018 12:22pm